(Q51910766)

English

Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane.

scientific article published in December 2006

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

0 references

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author name string

Masayoshi Konishi

1

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Motoh Iwasa

2

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Jun Araki

3

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Yoshinao Kobayashi

4

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Akira Katsuki

5

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Yasuhiro Sumida

6

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Naoki Nakagawa

7

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Yuji Kojima

8

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Shozo Watanabe

9

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Yukihiko Adachi

10

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Masahiko Kaito

11

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

publication date

1 December 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Journal of Gastroenterology and Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

21

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

12

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

1821-1825

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Superoxide dismutase in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Oxidative stress in viral and alcoholic hepatitis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Oxidants and antioxidants in alcohol-induced liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Oxidative stress in chronic hepatitis C: not just a feature of late stage disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Placental isoprostane is significantly increased in preeclampsia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Oxidant stress is a significant feature of primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Oxidative stress is associated with adiposity and insulin resistance in men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Oxidative status in chronic hepatitis C: the influence of antiviral therapy and prognostic value of serum hydroperoxide assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Effect of vitamin E on serum aminotransferase and thioredoxin levels in patients with viral hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04420.X

21 January 2018

Identifiers

10.1111/J.1440-1746.2006.04420.X

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 April 2018

http://europepmc.org/abstract/MED/17074020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51910766&oldid=1720658265"